Yifan Xinfu Pharmaceutical Co Ltd
Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 an… Read more
Yifan Xinfu Pharmaceutical Co Ltd (002019) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.005x
Based on the latest financial reports, Yifan Xinfu Pharmaceutical Co Ltd (002019) has a cash flow conversion efficiency ratio of 0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.18 Million) by net assets (CN¥8.71 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yifan Xinfu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Yifan Xinfu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yifan Xinfu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Universal Robina Corporation
PINK:UVRBF
|
0.017x |
|
Partner Communications Company Ltd.
PINK:PTNRF
|
0.104x |
|
Grupo Gigante S. A. B. de C. V
PINK:GPGNF
|
0.018x |
|
Aarti Industries Limited
NSE:AARTIIND
|
0.098x |
|
IMMUNOCORE HLDGS ADS/1
F:6YG
|
N/A |
|
Vizio Holding Corp
NYSE:VZIO
|
0.044x |
|
Alliance Financial Group Bhd
KLSE:2488
|
0.000x |
|
Shenzhen United Winners Laser Co Ltd
SHG:688518
|
0.024x |
Annual Cash Flow Conversion Efficiency for Yifan Xinfu Pharmaceutical Co Ltd (2003–2024)
The table below shows the annual cash flow conversion efficiency of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.43 Billion | CN¥640.73 Million | 0.076x | +80.06% |
| 2023-12-31 | CN¥8.25 Billion | CN¥348.58 Million | 0.042x | -18.18% |
| 2022-12-31 | CN¥9.15 Billion | CN¥472.07 Million | 0.052x | +50.34% |
| 2021-12-31 | CN¥8.77 Billion | CN¥301.23 Million | 0.034x | -72.96% |
| 2020-12-31 | CN¥8.73 Billion | CN¥1.11 Billion | 0.127x | +5.97% |
| 2019-12-31 | CN¥7.82 Billion | CN¥937.24 Million | 0.120x | -29.51% |
| 2018-12-31 | CN¥6.89 Billion | CN¥1.17 Billion | 0.170x | +1.79% |
| 2017-12-31 | CN¥6.78 Billion | CN¥1.13 Billion | 0.167x | -23.88% |
| 2016-12-31 | CN¥3.90 Billion | CN¥855.85 Million | 0.219x | +57.24% |
| 2015-12-31 | CN¥2.88 Billion | CN¥401.96 Million | 0.140x | +154.00% |
| 2014-12-31 | CN¥2.54 Billion | CN¥139.74 Million | 0.055x | -72.67% |
| 2013-12-31 | CN¥507.64 Million | CN¥102.05 Million | 0.201x | +223.45% |
| 2012-12-31 | CN¥480.81 Million | CN¥29.88 Million | 0.062x | +155.24% |
| 2011-12-31 | CN¥469.52 Million | CN¥-52.82 Million | -0.113x | -134.03% |
| 2010-12-31 | CN¥703.64 Million | CN¥-33.82 Million | -0.048x | -174.89% |
| 2009-12-31 | CN¥913.15 Million | CN¥58.61 Million | 0.064x | -56.02% |
| 2008-12-31 | CN¥570.87 Million | CN¥83.31 Million | 0.146x | -67.81% |
| 2007-12-31 | CN¥548.55 Million | CN¥248.71 Million | 0.453x | +337.09% |
| 2006-12-31 | CN¥314.44 Million | CN¥32.62 Million | 0.104x | +38.00% |
| 2005-12-31 | CN¥320.93 Million | CN¥24.12 Million | 0.075x | -30.63% |
| 2004-12-31 | CN¥309.98 Million | CN¥33.59 Million | 0.108x | -19.25% |
| 2003-12-31 | CN¥94.31 Million | CN¥12.65 Million | 0.134x | -- |